NOTE 15 – SUBSEQUENT EVENTS

Subsequent to the balance sheet date and through August 14, 2025 the Company issued an aggregate of 427,795 shares of common stock at a weighted average price of $7.34 per share through its At-The-Market (ATM) offering program, generating total gross proceeds of approximately $3,136,533.

On July 30, 2025, the Company priced a public offering of 6,666,667 shares of its common stock at $6.00 per share, resulting in net proceeds of approximately $37.1 million. The offering closed on August 1, 2025, and was conducted pursuant to an effective shelf registration statement on Form S-3. The Company also granted the underwriter a 30-day option to purchase up to an additional 838,851 shares and issued a warrant to purchase 333,334 shares at an exercise price of $7.20 per share.

On August 6, 2025, the Company made a $1,388,356 payment toward the principal and interest balance of the Notes entered into with 21 April Fund LP and 21 April Fund Ltd. on July 22, 2024. This payment reduced the outstanding principal obligation to zero and was made in accordance with the terms of the Notes.

On August 13, 2025, the Company provided notice of the termination, effective immediately, of the At-The-Market Issuance Sales Agreement, dated May 17, 2024, as amended by the First Amendment to At-The-Market Issuance Sales Agreement, dated April 14, 2025, and as further amended by the Second Amendment to At-The-Market Issuance Sales Agreement, dated May 27, 2025, between Ascendiant Capital Markets, LLC (“Ascendiant”) and the Company (the “Sales Agreement”).  As previously reported, pursuant to the terms of the Sales Agreement, the Company could sell shares of common stock having an aggregate sales proceeds of up to $18,000,000 through Ascendiant.  During the year ended December 31, 2024 and the six months ended June 30, 2025, the Company sold shares of common stock having aggregate gross proceeds of $3,544,689 and $5,790,814, respectively.  From July 1, 2025 through July 15, 2025 (the last day of sales under the Sales Agreement), the Company issued shares of common stock having an aggregate gross proceeds of $3,136,533, resulting in total gross proceeds of shares issued under the Sales Agreement of $12,472,036.  The Company will not make any further sales under the Sales Agreement.  The Company is not subject to any termination penalties related to the termination of the Sales Agreement.